Condition
Molecular Residual Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Molecular Residual Disease clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
See if ctDNA MRD testing can guide how long to keep immunotherapy in metastatic MSI-H/dMMR colorectal cancer
This study tests whether plasma ctDNA–based MRD testing can help decide when patients with metastatic MSI-H/dMMR colorectal cancer can safely stop immunotherapy after one year.
-
Unified network for a Yale liquid biopsy repository
This project tests collecting blood and tissue samples from Yale Cancer Center patients to build a shared liquid biopsy repository for current and future cancer research.
Quick answers
How many Molecular Residual Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.